SingHealth Duke-NUS Academic Medical Centre will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.
Close Icon
Subscribe Enews
Appointments
About Us
AM Initiatives
Academic Clinical Programmes
Research
Education
Innovation
Giving
Home Home A Phase 2 Randomized Double-blind Study of Adjuvant absolumaz With or Without A123 in Participants With Stage II to IIIB (N2) NSCLC with platinum-based Doublet Chemotherapy (IntSect-001)

A Phase 2 Randomized Double-blind Study of Adjuvant absolumaz With or Without A123 in Participants With Stage II to IIIB (N2) NSCLC with platinum-based Doublet Chemotherapy (IntSect-001)

Condition & treatments Specialty Published Date Study Description

Principal Investigator

Prof Balram Chowbay

Principal Investigator

Cellular ＆ Molecular Research
National Cancer Centre Singapore

Condition & treatments

  • Day Surgery

Specialty

Published Date

15 July 2025

Study Description

Condition Phase
Oncology II

Last Updated: 28 February 2026

  • About Us
  • Events
  • News

    • Follow Academic Medicines

    10 Hospital Boulevard, #19-01 SingHealth Tower Singapore 168582
    award 1 award 2 award 3 award 4

    © 2026 Singapore Health Services Pte Ltd. All Rights Reserved.

  • Terms of Use
  • Sitemap
  • PDPA
  • Rate Our Website
  • Report Vulnerability